<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2637116</article-id><article-id pub-id-type="doi">10.1371/annotation/eaf9794a-9325-4977-952d-51285c3f6c6a</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy</article-title><alt-title alt-title-type="running-head">Correction</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Arnon</surname><given-names>Tal I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Markel</surname><given-names>Gal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bar-Ilan</surname><given-names>Ahuva</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hanna</surname><given-names>Jacob</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fima</surname><given-names>Eyal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Benchetrit</surname><given-names>Fabrice</given-names></name></contrib><contrib contrib-type="author"><name><surname>Galili</surname><given-names>Ruth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cerwenka</surname><given-names>Adelheid</given-names></name></contrib><contrib contrib-type="author"><name><surname>Benharroch</surname><given-names>Daniel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sion-Vardy</surname><given-names>Netta</given-names></name></contrib><contrib contrib-type="author"><name><surname>Porgador</surname><given-names>Angel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mandelboim</surname><given-names>Ofer</given-names></name></contrib></contrib-group><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>19</day><month>5</month><year>2008</year></pub-date><volume>3</volume><issue>5</issue><elocation-id>10.1371/annotation/eaf9794a-9325-4977-952d-51285c3f6c6a</elocation-id><copyright-statement>Public Library of Science. This is an open-access article                distributed under the terms of the Creative Commons Attribution License, which                permits unrestricted use, distribution, and reproduction in any medium, provided the                original work is properly cited.</copyright-statement><copyright-year>2008</copyright-year><related-article related-article-type="corrected-article" vol="3" page="e2150" id="N0x1c44850N0x1e516e0" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="18478075" ext-link-type="pubmed"><article-title>Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy</article-title></related-article></article-meta></front><body><p>The funding information for this paper is missing. It should read:</p><p>This work was supported by the Israel Science Foundation (O.M.), the Binational Science Foundation (O.M.), the AICR (O.M), the ICRF (O.M.), the European Commission (LSHC-CT-2002-518178 and MRTN-CT-2005 to O.M.), the Israel Ministry of Health (A.P.), the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ), and Israeli's Ministry of Science and Technology (MOST) (A.P.).</p></body></article>